PremiumPre-EarningsVRCA Earnings Report this Week: Is It a Buy, Ahead of Earnings? Verrica Pharmaceuticals Announces Resignation of Chief Legal Officer Cautious Outlook on Verrica Pharmaceuticals Amid Restructuring and Market Challenges PremiumCompany AnnouncementsVerrica Pharmaceuticals’ Earnings Call: Growth Amid Challenges Strategic Growth and Market Positioning Drive Buy Rating for Verrica Pharmaceuticals Verrica Pharmaceuticals Reports Positive Q4 2024 Results PremiumThe FlyVerrica Pharmaceuticals provides update on new commerical strategy for YCANTH Verrica Pharmaceuticals Appoints New Chief Operating Officer Verrica announces development partner Torii files NDA for TO-208 in Japan 
